Industry Webcast

Early Signs to Early Action: Diagnosing and Managing Excess Adiposity as a Cardiometabolic Risk DriverIndustry Webcast Sponsored by Eli Lilly & Company; Not for CME/CE Credit

This educational program is designed to help primary care clinicians recognize excess adiposity earlier in the disease continuum and understand its role as a key driver of cardiometabolic risk. Through practical, evidence-based guidance, participants will explore how to identify early clinical signs and obesity-related complications, apply current diagnostic and staging approaches beyond BMI alone, and implement timely interventions to reduce the risk of disease progression.